The acquisition of BioFund Management Oy (BioFund) is final. BioFund will become a subsidiary member of the Capinordic Group, and Capinordic thereby gains a landmark within the investment in and supply of life science products.
BioFund manages the portfolios of a number of life science venture funds with a total commitment of EUR 200 million. Through these venture funds, BioFund has invested in 47 companies, mainly in the Nordic countries, but also in the rest of Europe and North America. The current portfolio comprises 18 companies.
Through BioFund, the existing subsidiaries of the Group will be able to offer investments in the attractive life science market.
The Capinordic Group can offer BioFund a substantial deal flow and corporate finance expertise in connection with the implementation of and exit from investments.
Company Announcement No. 4/2008